about
The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000.Update on the burden of Campylobacter in developing countries.Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.Rotavirus infection and disease in a multi-site birth cohort: Results from the MAL-ED study.Determinants and Impact of Giardia Infection in the First 2 Years of Life in the MAL-ED Birth Cohort.Use of antibiotics in children younger than two years in eight countries: a prospective cohort study.Dynamics and Trends in Fecal Biomarkers of Gut Function in Children from 1-24 Months in the MAL-ED Study.Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast BrazilPlasma Tryptophan and the Kynurenine-Tryptophan Ratio are Associated with the Acquisition of Statural Growth Deficits and Oral Vaccine Underperformance in Populations with Environmental Enteropathy.Epidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings: Results From the MAL-ED Study.Fecal Markers of Environmental Enteropathy and Subsequent Growth in Bangladeshi Children.Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study.Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED).The MAL-ED cohort study: methods and lessons learned when assessing early child development and caregiving mediators in infants and young children in 8 low- and middle-income countries.Assessment of environmental enteropathy in the MAL-ED cohort study: theoretical and analytic framework.Methods of analysis of enteropathogen infection in the MAL-ED Cohort Study.Microbiologic methods utilized in the MAL-ED cohort studyCryptosporidiosis: an update.Magnitude and impact of diarrheal diseases.Causal Pathways from Enteropathogens to Environmental Enteropathy: Findings from the MAL-ED Birth Cohort StudyA Comparison of Diarrheal Severity Scores in the MAL-ED Multisite Community-Based Cohort StudyPostpartum depressive symptoms across time and place: structural invariance of the Self-Reporting Questionnaire among women from the international, multi-site MAL-ED studyMeasuring socioeconomic status in multicountry studies: results from the eight-country MAL-ED study.Lactulose: mannitol diagnostic test by HPLC and LC-MSMS platforms: considerations for field studies of intestinal barrier function and environmental enteropathy.Detection of Campylobacter in stool and determination of significance by culture, enzyme immunoassay, and PCR in developing countries.REG1B as a predictor of childhood stunting in Bangladesh and Peru.Setting priorities for development of emerging interventions against childhood diarrhoea."Barriers" to child development and human potential: the case for including the "neglected enteric protozoa" (NEP) and other enteropathy-associated pathogens in the NTDs.Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants.Household food access and child malnutrition: results from the eight-country MAL-ED study.Diarrhea and reduced levels of antiretroviral drugs: improvement with glutamine or alanyl-glutamine in a randomized controlled trial in northeast Brazil.Age and Sex Normalization of Intestinal Permeability Measures for the Improved Assessment of Enteropathy in Infancy and Early Childhood: Results from the MAL-ED Study.Early Antibiotic Exposure in Low-Resource Settings is Associated with Increased Weight in The First Two Years of Life.Setting research priorities to reduce global mortality from childhood diarrhoea by 2015.An instrument for the assessment of diarrhoeal severity based on a longitudinal community-based studyComparison of the immune microenvironment of the oral cavity and cervix in healthy womenInfant Nutritional Status, Feeding Practices, Enteropathogen Exposure, Socioeconomic Status, and Illness Are Associated with Gut Barrier Function As Assessed by the Lactulose Mannitol Test in the MAL-ED Birth Cohort.Evaluating associations between vaccine response and malnutrition, gut function, and enteric infections in the MAL-ED cohort study: methods and challengesSymptomatic and asymptomatic Campylobacter infections associated with reduced growth in Peruvian children.Seroepidemiology of strongyloidiasis in the Peruvian Amazon.
P50
Q24648889-307F6D03-49D4-4CCA-8306-EDA08B10D504Q26861272-3AA9FC80-BA6D-4993-9D0D-000BCF61BA86Q30249278-D6EB0780-E796-46D8-900E-2AEB9201CC79Q30252454-8C545513-75CD-4BB9-B613-F45463B5DC72Q30274756-8C05C078-9FE0-4772-950B-016FC4AF112CQ30275100-8D25CADD-A3FA-48D7-8B32-E59A1BBA0253Q30275186-3120C9D7-28E5-4DE8-8C49-B2C2F775258CQ30275811-368BE772-23F4-42B0-AF64-B7BAE97CE7BEQ30276161-109EB2F4-D00F-4583-8CE2-C1D32E620FD3Q30276167-7E565B20-4B65-4C57-B692-B60B86C07885Q30276480-0950DB39-DC70-435C-8B3A-3AAB0E0AD900Q30277091-EA96A0E8-A321-4A0D-A1DB-BCFEE629D602Q30278967-3F77BC99-4526-4202-BF5C-FFE6C44D476AQ30303117-ACB3E00E-9F6B-4487-98C4-4EFD84E06253Q30303118-769F4C01-0513-4A29-9EFC-AD6A728833FFQ30303119-0103425B-3078-4A93-A4A1-8513B0E9D33AQ30303120-3792C2C5-0E2D-457D-98A8-7DA5235A6F28Q30308822-8A08A38A-F904-4098-A72A-A1BB63724BD6Q30309920-4D7868AE-7F90-400C-A76B-A252F51BEAD1Q30352850-FC59B65D-7F71-43B4-BC81-6F32890EDE60Q30355334-0E580610-FBED-45D2-B410-504660C34FDFQ30370640-B59A29B0-E236-428A-8C7D-05AE12FF4CB0Q30409492-52BEFFD2-98F8-4ED6-B148-FCFCE3253451Q30409601-45C14AD2-A121-433C-A6F2-8E34B549B3CCQ30410458-90E921CB-4E16-4AEE-82F7-0838751D591BQ30413251-05069E1E-CC22-4C4E-A816-2335510D16AFQ30418380-A9D3C04B-50D7-4A56-9DDC-950130888C32Q30419953-684CE095-D172-4189-BB96-1F4BFF7205D5Q30421984-1D94BD97-2598-40EC-84FB-E41E9374F488Q30422056-5DCD4672-E5AA-4E32-B5F7-EF65E66F3CB5Q30433860-20B431EC-6AE8-4C27-9515-32692DE92074Q30491587-3F5BEDC5-9FA1-46CB-BB40-F3F0E2394C26Q30491976-91FBA908-0A91-46E9-B928-C71212655ED7Q33417039-C1FE1029-C58E-4175-B01D-80C1B9B4636BQ33744811-9B69E4B1-E2C3-4BEA-B8C9-45E4678C06E1Q33823775-7F79D3B1-B807-4401-B322-FB2A5D8B4926Q33901797-5036416A-4AC1-4607-84C0-BA647C2C9226Q34378070-39447B65-8B31-4E45-88E1-A648578D666DQ34577254-F80243B3-02C3-4885-977A-3F148680E66DQ34700797-3F0FF12E-91FC-461A-835D-E031B60633E5
P50
description
researcher ORCID ID = 0000-0001-6340-4852
@en
wetenschapper
@nl
name
Margaret N Kosek
@ast
Margaret N Kosek
@en
Margaret N Kosek
@es
Margaret N Kosek
@nl
type
label
Margaret N Kosek
@ast
Margaret N Kosek
@en
Margaret N Kosek
@es
Margaret N Kosek
@nl
prefLabel
Margaret N Kosek
@ast
Margaret N Kosek
@en
Margaret N Kosek
@es
Margaret N Kosek
@nl
P214
P1153
6701330606
P21
P214
P31
P496
0000-0001-6340-4852
P734
P735
P7859
viaf-305737101